Side-by-side comparison of AI visibility scores, market position, and capabilities
Beverly Hills live entertainment (NYSE: LYV) $23.2B FY2024 revenue (+6.7%); Ticketmaster 550M+ tickets, Taylor Swift Eras Tour $2.08B, DOJ antitrust breakup case, competing with AEG Presents.
Live Nation Entertainment, Inc. is a Beverly Hills, California-based live entertainment company — publicly traded on the New York Stock Exchange (NYSE: LYV) as an S&P 500 Communication Services component — operating as the world's largest live entertainment company through three integrated business segments: Concerts (promoting and producing 40,000+ events annually featuring 5,500+ artists at Live Nation-operated and third-party venues worldwide), Ticketing (Ticketmaster — the dominant US and global ticketing platform processing 550+ million tickets annually), and Sponsorship & Advertising (brand partnership and naming rights revenue across Live Nation venues and events) through approximately 44,000 employees globally. In fiscal year 2024, Live Nation reported revenues of $23.2 billion (+6.7% year-over-year), with concerts segment revenue growing on sustained post-COVID touring normalization and stadium-scale demand for A-list artists (Taylor Swift's Eras Tour — the highest-grossing concert tour in history at $2.08 billion globally in 2023-2024 — Beyoncé Renaissance tour, Coldplay, Morgan Wallen creating record venue sell-throughs). CEO Michael Rapino has executed Live Nation's vertically integrated live entertainment flywheel for two decades: artist management (Front Line Management), concert promotion (Live Nation Concerts), venue operation (House of Blues, Palladium, Amphitheater network — 350+ owned/operated venues), and ticketing (Ticketmaster) — creating a system where artists book through Live Nation-managed agents, play Live Nation-promoted shows, in Live Nation-operated venues, with tickets sold exclusively through Ticketmaster, capturing revenue at every transaction layer.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.